GI
GRTS

Gradient Investments’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Gradient Investments’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-22
Closed -$61 – 1899
2023
Q1 		$61 Hold
22
– – ﹤0.01% 1466
2022
Q4 		$76 Hold
22
– – ﹤0.01% 1439
2022
Q3 		$0 Hold
22
– – ﹤0.01% 1575
2022
Q2 		$0 Buy
+22
New +$58 ﹤0.01% 1411

Other funds holding GRTS

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gradient Investments's GRTS Position: Q2 2023 in Review

Gradient Investments sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2023, closing a stake of 22 shares — an estimated $61 sold.

Gradient Investments first reported a position in GRTS in Q2 2022 and held it in 4 quarters. The position peaked at $76 in Q4 2022. 88 funds tracked by Wall St. Rank hold GRTS as of Q2 2023.

  • Gradient Investments reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Gradient Investments sold 22 Gritstone bio, Inc. Common Stock shares in Q2 2023, an estimated $61.
  • Gradient Investments first reported a position in Gritstone bio, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Gradient Investments's Gritstone bio, Inc. Common Stock position peaked at $76 in Q4 2022.
  • 88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2023.

Based on Gradient Investments's 13F filing for Q2 2023, filed 11 Jul 2023.